GSE210718 SHMT2 knockdown 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE210718_SHMT2 knockdown_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE210718_SHMT2 knockdown_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE210718_SHMT2 knockdown_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE210718_SHMT2 knockdown_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

OIP5 antisense RNA 1

Gene

mitochondrial ribosomal protein L45

Gene

small nucleolar RNA host gene 15

Gene

urothelial cancer associated 1

Gene

long intergenic non-protein coding RNA, p53 induced transcript

Gene

ABCF2-H2BK1 readthrough

Gene

long intergenic non-protein coding RNA 2984

Gene

HIF1A antisense RNA 3

Gene

FAM111A divergent transcript

Gene

MIR155 host gene

  • Gene

    OIP5 antisense RNA 1


  • Gene

    mitochondrial ribosomal protein L45


  • Gene

    small nucleolar RNA host gene 15


  • Gene

    urothelial cancer associated 1


  • Gene

    long intergenic non-protein coding RNA, p53 induced transcript


  • Gene

    ABCF2-H2BK1 readthrough


  • Gene

    long intergenic non-protein coding RNA 2984


  • Gene

    HIF1A antisense RNA 3


  • Gene

    FAM111A divergent transcript


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.